RespireRx Pharmaceuticals Market Cap

RespireRx Pharmaceuticals has a market cap or net worth of $1.80 million as of December 27, 2024. Its market cap has increased by 571.88% in one year.

Market Cap

1.80M

Enterprise Value

5.39M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 1, 1992, RespireRx Pharmaceuticals's market cap has decreased from 26.39M to 1.80M, a decrease of -93.16%. That is a compound annual growth rate of -7.88%.

Market Cap History

Date	Market Cap	% Change
Dec 27, 2024	1.80M	293.25%
Dec 29, 2023	458.74K	58.87%
Dec 30, 2022	288.75K	-74.38%
Dec 31, 2021	1.13M	-45.46%
Dec 31, 2020	2.07M	411.01%
Dec 31, 2019	404.47K	-82.66%
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	18.07B
Telix Pharmaceuticals Limited	5.20B
Elekta AB (publ)	2.09B
Ryman Healthcare Limited	1.72B
Verano Holdings Corp.	463.76M
Vireo Growth Inc.	129.65M
Medexus Pharmaceuticals Inc.	55.68M

Market Cap Rankings